Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Zymeworks Inc. ZYME

Zymeworks Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development and commercialization of next-generation multifunctional biotherapeutics. Its suite of therapeutic platforms and its fully integrated drug development engine enable precise engineering of differentiated product candidates. Its lead clinical candidate, zanidatamab, is a novel Azymetric HER2-targeted bispecific antibody currently being evaluated in multiple Phase 1, Phase 2, and pivotal clinical trials globally as a targeted treatment option for patients with solid tumors that express HER2. The company is also advancing a deep preclinical pipeline in oncology and other therapeutic areas.

The Market Herald Price Sensitive
{{currentVideo.title}} {{currentVideo.relativeTime}}
{{currentVideo.storiesTitle}}:
{{story.companySymbol}}
{{story.companySymbol}} {{story.headline}}
< Previous bulletin
Next bulletin >
View modes: 

Nice move today

Nice move today. I added.  Looks like a good buy. Still doing DD  rate and reply

Update on ABC Offer for ZYME

By Jonathan Braude May 05, 2022 09:24 AM Dubai-based private equity investor All Blue Capital Ltd. is prepared to go hostile with its $733 million takeover offer for Canadian drug developer ...read more

All Blue Falcons holdings

According to one website ABF owns over 3M shares of Zymeworks already....so if that is true it would seem to make sense for them to make this kind of offer. My guess is that the board will try to hold...read more

How is Ken Galbraith leading the turnaround at Zymeworks???

Why Ken Galbraith? Zymeworks was owned by institutions at 82% before the recent financing, 18% by retail. After the dilution, 62% institutions, 35% retail. These latest numbers clearly show that...read more

Kenneth Galbraith - Zymeworks - Public Offering

In the spring of 2018, Prometic is given a median valuation of just under $6 BILLION (that's right, BILLION) by Morgan Stanley. Just about a year later, in April 2019, Prometic is acquired by...read more

ARMISTICE CATCH UP AGAIN

ARMISTICE is one of the ten big funds which togeder represent more than 50% of Zymeworks. They have skin in the game. Unfortunately ARMISTICE was cheated  in its deal with Liminal whose CEO was...read more

Keneth Galbraith

Galbraith is brought into a company when unethical measures are required to destroy potential. Be mindful of the devil now in charge.  You’ve been warned!! Galbraith currently faces an almost...read more

RE:WHO will throw the towel first ?

Did I see a towel flying today?  rate and reply

WHO will throw the towel first ?

This statement comes from the third quarter results "As of September 30, 2021, Zymeworks had $307.8 million in cash resources consisting of cash, cash equivalents and short-term...read more

GALBRAITH THE STORY BEHIND

WHAT REALLY HAPPENED ? I the last three years Zymeworks raised close to $600millions. The company has no revenue from operation and a $170 millions burn rate a year without solid scientific results....read more

Kenneth Galbraith

WOW! What a pick up! You realy are on big tobble to hire that LEADER who never deliver the goods everywere he were. He promised to rebuilt and save  Prometic for the benefit of shareholders. He...read more

RE:RE:Ken Galbraith CEO - good luck

One final thought - in the company press release which refers the business wire article, there is absolutely no mention of his involvement in the debacle at Prometic Life Sciences /  Liminal...read more

RE:Ken Galbraith CEO - good luck

I saw the news and figured I would warn investors here on this board but you beat me to it. I will echo the same sentiment. Full disclosure I do not hold any ZYME but given Galbreath's history...read more

Ken Galbraith CEO - good luck

They sure got a winner here. He is named in lawsuit on Prometic Life Sciences and Liminal Biosciences. Produced tons of shareholder value for Thomson family but destroyed all retailers. Beware. This...read more

RE:What is management doing?

see friday trades.,   not much doing all morning,  dropped down to 18.96 at the bottom. then suddenly at 1pm it climbed up a dollar to 20.00+ within the hour. the market makers...read more

What is management doing?

At this rate of share price decline, ZYME will be a penny stock within months. What the he ll is management doing to help support the stock. If the next read-out is poor ZYME will be decimated.  ...read more

RE:Slides to today’s conference…

So  their product is Zanidatamab for GastroIntestinal Cancer,  the clinical trials look good. Now they are setting up a full scale trial in 300 sites over 38 countries - looking for approval...read more

RE:RE:what's not to like about ZYME ?

Thanks gringotts,  after considering what you have said, I think I should get a few more. Will wait until I see an upward trajectory developing though.  If the Zyme rep made a good...read more

Slides to today’s conference…

Link to the presentation slides used at today's conference   https://ir.zymeworks.com/static-files/ec2ab511-256d-44c4-9b5e-aba93f3ec09c   Major take away: BLOCKBUSTER peak sales...read more

RE:what's not to like about ZYME ?

It is heartening to know someone is reading and posting on the Zyme billboard. By the way, I agree. The vast majority of shares are owned by investment companies.   The share price slide from...read more